Summary
Profile
Financials
Events
Ownership
Options

Company Info

Industry Biotechnology
Sector Health Technology
Employees 129
CEO Mr. Ian C. Mortimer
Address 3650 Gilmore Way Suite 200, Burnaby, BC V5G 4W8
Phone 1.604.484.3300
Website www.xenon-pharma.com

Xenon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. The company's products include XEN496, XEN1101, XEN901 and XEN007. Xenon Pharmaceuticals was founded by Simon Neil Pimstone, Johannes J. P. Kastelein and Michael R. Hayden on November 5, 1996 and is headquartered in Burnaby, Canada.

Competitors

Company Name 3 Month
%Change
1 Year
%Change
Xenon Pharmaceuticals, Inc. 66.82% 175.25%
Hill-Rom Holdings, Inc. 31.22% 71.21%
Neurocrine Biosciences, Inc. 10.01% 2.42%
Zai Lab Ltd. -34.25% 15.72%
Penumbra, Inc. 6.22% 27.55%

Statement Summary

as of 4:00 ET PM 10/18/2021
Total Assets (MRQ) 274.7 M
Total Liabilities (MRQ) 17.7 M
Shareholders’ Equity (MRQ) 257.0 M
Total Revenue (Annual) 2.2 M
Net Income (Annual) -22.1 M

Earnings And Estimates

as of 4:00 ET PM 10/18/2021

Current Qtr EPS Estimate -0.37
Current FY EPS Estimate -1.65
Long Term EPS Growth Estimate 61.10
Next Expected Earnings Date 11/9/2021

XENE vs S&P 500

as of 10/18/2021
Relative To
S&P 500
XENE
4 Weeks n/a n/a
12 Weeks n/a n/a
YTD n/a n/a

Earnings Surprises

as of 4:00 ET PM 10/18/2021
Fiscal Quarter Estimate Actual Surprise
06/2021 -0.48 -0.51 +6.53%
03/2021 -0.43 -0.42 -2.89%
12/2020 -0.39 -0.34 -13.45%
09/2020 -0.11 -0.25 +130.26%
06/2020 -0.24 0.00 -100.00%
03/2020 -0.32 -0.22 -31.68%
12/2019 -0.48 -0.42 -12.50%
09/2019 -0.44 -0.33 -25.00%

Financial Strength

as of 4:00 ET PM 10/18/2021
Pre-Tax Margin -1.00
Net Margin -76.00
Operating Margin -1.00
Return On Equity -26.46
Return On Assets -24.33
Inventory Turnover (TTM) 0.00
Sales Growth (MRQ) 15.61

Ratios

as of 4:00 PM ET 10/18/2021
Price/Earnings (TTM) n/a
Price/Book (MRQ) 5.07
Price/Cash Flow (TTM) 0.00
Book Value (MRQ) 6.06
Quick Ratio (MRQ) 17.81
Current Ratio (MRQ) 17.81
Total Debt/Equity (MRQ) 0.01

Short Interest

as of 4:00 PM ET 10/19/2021
% Short - 0.00%
% Remaining Float - 100.00%
Current Last Month
Short Interest Date n/a n/a
Short Interest Shares 0 0
Short Interest Ratio 0.0 0.0
M Y M Y
Total Assets 0,0.00 0,0.00
Total Liabilities 0,0.00 0,0.00
Total Equity 0,0.00 0,0.00
M Y M Y
Total Revenue 0,0.00 0,0.00
EBT Exc.
Unusual Items
0,0.00 0,0.00
Net Income 0,0.00 0,0.00
M Y M Y
Cash from
Operations
0,0.00 0,0.00
Cash from
Activities
0,0.00 0,0.00
Cash from
Fin. Activities
0,0.00 0,0.00

TOTAL ASSETS

TOTAL LIABILITIES

TOTAL EQUITY

Balance Sheet

M Y
ASSETS
Cash And Equivalents 0,0.00
Receivables 0,0.00
Inventories 0,0.00
Other Current Assets 0,0.00
Total Current Assets 0,0.00
Property, Plant & Equipment, Gross 0,0.00
Accumulated Depreciation & Depletion 0,0.00
Property, Plant & Equipment, Net 0,0.00
Intangibles 0,0.00
Other Non-Current Assets 0,0.00
Total Non-Current Assets 0,0.00
TOTAL ASSETS 0,0.00
Liabilities & Shareholder Equity
Accounts Payable 0,0.00
Short Term Debt 0,0.00
Total Current Liabilities 0,0.00
Long Term Debt 0,0.00
Deferred Income Taxes 0,0.00
Other Non-Current Liabilities 0,0.00
Minority Interest 0,0.00
Total Non-Current Liabilities 0,0.00
Preferred Stock Equity 0,0.00
Common Stock Equity 0,0.00
Common Par 0,0.00
Additional Paid In Capital 0,0.00
Cumulative Translation Adjustment 0,0.00
Retained Earnings 0,0.00
Treasury Stock 0,0.00
Other Equity Adjustments 0,0.00
Total Capitalization 0,0.00
TOTAL EQUITY 0,0.00
TOTAL LIABILITIES & STOCK EQUITY 0,0.00
Total Common Shares Outstanding 0,0.00
Preferred Shares 0,0.00
Treasury Shares 0,0.00
Basic Weighted Shares Outstanding 0,0.00
Diluted Weighted Shares Outstanding 0,0.00
Number Of Employees 0,0.00
Number Of Part-Time Employees 0,0.00

TOTAL REVENUES

EBT Excluding Unusual Items

NET INCOME

Income Statement

M Y
Sales 0,0.00
Cost Of Sales 0,0.00
Gross Operating Profit 0,0.00
Selling, General, And Administrative Expenses 0,0.00
Research & Development 0,0.00
Operating Income Before D & A (EBITDA) 0,0.00
Depreciation & Amortization 0,0.00
Interest Income 0,0.00
Other Income - Net 0,0.00
Special Income / Charges 0,0.00
Total Income Before Interest Expenses (EBIT) 0,0.00
Interest Expense 0,0.00
Pre-Tax Income 0,0.00
Income Taxes 0,0.00
Minority Interest 0,0.00
Net Income From Continuing Operations 0,0.00
Net Income From Discontinued Operations 0,0.00
Net Income From Total Operations 0,0.00
Extraordinary Income/Losses 0,0.00
Income From Cum. Effect Of Acct. Change 0,0.00
Income From Tax Loss Carryforward 0,0.00
Other Gains / Losses 0,0.00
Total Net Income 0,0.00
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0,0.00
Preferred Dividends 0,0.00
Net Income Available To Common 0,0.00
Basic EPS From Continuing Ops. 0,0.00
Basic EPS From Discontinued Ops. 0,0.00
Basic EPS From Total Operations 0,0.00
Basic EPS From Extraordinary Inc. 0,0.00
Basic EPS From Cum Effect Of Accounting Change 0,0.00
Basic EPS From Tax Loss Carryf'd. 0,0.00
Basic EPS From Other Gains (Losses) 0,0.00
Basic EPS, Total 0,0.00
Basic Normalized Net Income/Share 0,0.00
EPS From Continuing Ops. 0,0.00
EPS From Discontinued Ops 0,0.00
EPS From Total Ops. 0,0.00
EPS From Extraord. Inc. 0,0.00
EPS From Cum Effect of Accounting Change 0,0.00
EPS From Tax Loss Carfd. 0,0.00
EPS From Other Gains (L) 0,0.00
EPS, Total 0,0.00
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0,0.00
Dividends Paid Per Share 0,0.00

CASH FROM OPERATIONS

CASH FROM INVESTING ACTIVITIES

CASH FROM FINANCING ACTIVITIES

Cash Flow Statement

M Y
Cash Flow From Operating Activities
Net Income (Loss) 0,0.00
Operating Gains/Losses 0,0.00
Gross Operating Profit 0,0.00
(Increase) Decrease In Receivables 0,0.00
(Increase) Decrease In Inventories 0,0.00
(Increase) Decrease In Other Current Assets 0,0.00
(Decrease) Increase In Other Current Liabilities 0,0.00
(Increase) Decrease In Other Working Capital 0,0.00
Other Non-Cash Items 0,0.00
Net Cash From Continuing Operations 0,0.00
Net Cash From Discontinued Operations 0,0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 0,0.00
Sale Of Property, Plant & Equipment 0,0.00
Cash Used For Investing Activities
Sale Of Short-Term Investments 0,0.00
Purchases Of Property, Plant & Equipment 0,0.00
Acquisitions 0,0.00
Purchases Of Short-Term Investments 0,0.00
Other Cash From Investing Activities 0,0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities 0,0.00
Issuance Of Debt 0,0.00
Cash Used For Financing Activities
Issuance Of Capital Stock 0,0.00
Repayment Of Long-Term Debt 0,0.00
Repurchase Of Capital Stock 0,0.00
Payment Of Cash Dividends 0,0.00
Other Financing Charges, Net 0,0.00
Net Cash From Financing Activities 0,0.00
Effect Of Exchange Rate Changes 0,0.00
Net Change In Cash & Cash Equivalents 0,0.00

Earnings Estimates

as of 4:00 ET PM 10/18/2021
Current Qtr
(09/2021)
Next Qtr
(12/2021)
Consensus Estimate $-0.37 $-0.37
# of Estimates 8 8
High Estimate $0.05 $-0.17
Low Estimate $-0.54 $-0.75
Year Ago EPS $-0.25 $-0.34
Year Over Year Growth Estimate 49.45% 7.09%
Current Yr
(12/2021)
Next Yr
(12/2022)
Consensus Estimate $-1.65 $-2.02
# of Estimates 9 9
High Estimate $-1.34 $-1.71
Low Estimate $-2.11 $-2.36
Year Ago EPS $-0.81 $-1.65
Year Over Year Growth Estimate 103.57% 22.57%
Current Qtr
(09/2021)
Next Qtr
(12/2021)
Current Year
(12/2021)
Next Year
(12/2022)
Consensus Estimate $-0.37 $-0.37 $-1.65 $-2.02
# of Estimates 8 8 9 9
High Estimate $0.05 $-0.17 $-1.34 $-1.71
Low Estimate $-0.54 $-0.75 $-2.11 $-2.36
Year Ago EPS $-0.25 $-0.34 $-0.81 $-1.65
Year Over Year Growth Estimate 49.45% 7.09% 103.57% 22.57%

Insider Information Summary

as of 09/30/2021
% Insiders - 8.63%
% Remaining Total Shares - 91.37%
Current 1 Month
Net Insider Transaction 0.00 30.77 K
Shares Bought 0.00 51.44 K
Shares Sold 0.00 20.67 K

Insider Activity

Transaction Date Insider/Title Transaction Type Market Value Shares Average Price Current Holdings

LATEST NEWS

Recent Articles from TheStreet

United Airlines

United Airlines Third-Quarter Sales Beat Estimates

United Airlines shares rose after hours Tuesday as it released third-quarter earnings that showed its sales beat analyst estimates.

Bitcoin Lead

Deporre: Bitcoin Miners Drawing Fresh Interest

Ahead of the first bitcoin ETF, 'Rev Shark' saw lots of intensity in the market.

stocks market index sh

Cramer's Mad Money Recap 10/19: Chevron, Wells Fargo, Nvidia

Jim Cramer take a look at the stocks he says are poised to profit even when inflation is rising.

Canadian National Railway Avoids Labor Strike

Canadian National Jumps on CEO Departure Announcement

Campaign for new management by investor group followed failed bid for Kansas City Southern

Hang Seng Index Compiler Says It Will Be Tough To Meet Target Of 80 Constituent Stocks By Next Year

BlackRock's Rieder: Stocks Could Rise Up to 10% by Year-End

'Could you get another 5 to 8% out of the market, … maybe even 10%? I think so,' Blackrock's CIO Rick Rieder told CNBC.

Hong Kong Online Brokerage Banks On US Parent As It Targets Younger Traders With App-based Services

Heller: Triple Net Active Portfolio Wins by a Nose

Strategy of selecting companies at low net current asset values tops benchmarks.

U.S. Justice Department Preparing Charges Against Banks

Facebook Settles DOJ Lawsuit And Labor Department Audit

Facebook settles a lawsuit by the Department of Justice and an audit by the Department of Labor over the PERM hiring program.

Squid Game Lead

Netflix Q3 Earnings Almost Double on Success of 'Squid Game'

Netflix adds 4.4 million subscribers in the third quarter and sees another 8.5 million additions over the final three months of the year.

12. Netflix flies high as Old Media scrambles to respond

Netflix Third-Quarter Earnings Live Blog

Real Money's Eric Jhonsa covers Netflix's third-quarter earnings report and video interview with management.

Oil Inventories Lead

Energy Inflation Hits An Already-Battered Manufacturing Sector

All parts of supply chains are affected by higher prices for oil, natural gas and coal, Real Money's Action Alerts Plus team writes.